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Background: Xanthine oxidase (XO) is a complex molybdeno-flavoprotein occurring with high activity 
in the milk fat globule membrane (MFGM) in all mammalian milk and is involved in the final stage of 
degradation of purine nucleotides. It catalyzes the sequential oxidation of hypoxanthine to xanthine 
and uric acid, accompanied by production of hydrogen peroxide and superoxide anion. Human saliva 
has been extensively described for its composition of proteins, electrolytes, cortisol, melatonin and 
some metabolites such as amino acids, but little is known about nucleotide metabolites. 
Method: Saliva was collected with swabs from babies; at full-term 1-4 days, 6-weeks, 6-months and 
12-months. Unstimulated fasting (morning) saliva samples were collected directly from 77 adults. 
Breast milk was collected from 24 new mothers. Saliva was extracted from swabs and ultra-filtered. 
Nucleotide metabolites were analyzed by RP-HPLC with UV-photodiode array and ESI-MS/MS. XO 
activity was measured as peroxide production from hypoxanthine. Bacterial inhibition over time was 
assessed using CFU/mL or OD.  
Results: Median concentrations (µmol/L) of salivary nucleobases and nucleosides for neonates/6-
weeks/6-months/12-months/adult respectively were: uracil 5.3/0.8/1.4/0.7/0.8, hypoxanthine 
27/7.0/1.1/0.8/2.0, xanthine 19/7.0/2.0/2.0/2.0, adenosine 12/7.0/0.9/0.8/0.1, inosine 
11/5.0/0.3/0.4/0.2, guanosine 7.0/6.0/0.5/0.4/0.1, uridine 12/0.8/0.3/0.9/0.4. Deoxynucleosides and 
dihydropyrimidines concentrations were essentially negligible. XO activity (Vmax:mean ± SD) in 
breast milk was 8.9 ± 6.2 µmol/min/L and endogenous peroxide was 27 ± 12 µmol/L; mixing breast 
milk with neonate saliva generated ~40 µmol/L peroxide,which inhibited Staphylococcus aureus. 
Conclusions: Salivary metabolites, particularly xanthine/hypoxanthine, are high in neonates, 
transitioning to low adult levels between 6-weeks to 6-months (p < 0.001). Peroxide occurs in breast 
milk and is boosted during suckling as an antibacterial system. 
 
